A Potential Universal Target for Autoimmune: Q&A with Richard Freed
August 4, 2025
- News
Pharmaceutical Executive recently spoke with RheumaGen CEO Richard Freed about his career and the work the biotech is doing to find cures for autoimmune diseases.